Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com
(TheNewswire) Vancouver, British Columbia June 4 th 2025 TheNewswire – Juggernaut Exploration Ltd. (TSX-V: JUGR) (OTCQB: JUGRF) (FSE: 4JE)…
triumph gold Corp. (TSXV: TIG) (OTC Pink: TIGCF) (FSE: 8N6) (‘triumph gold’ or the ‘Company’) is pleased to announce…
LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) (‘LaFleur Minerals’ or the ‘Company’) is pleased to provide the…
(TheNewswire) Global private financial group headquartered in San Francisco advises on construction facility to support CHARBONE’s expansion of modular…
(TheNewswire) Un groupe financier privé mondial dont le siège social est à San Francisco conseille sur la facilité de…
West High Yield (W.H.Y.) Resources Ltd. (TSXV: WHY) (FSE: W0H) (the ‘Company’ or ‘West High Yield’) announces announces the…
